Changing causes of mortality for people with chronic respiratory diseases

A. Gayle (London, United Kingdom), E. Axson (London, United Kingdom), C. Bloom (London, United Kingdom), V. Navaratnam (Nottingham, United Kingdom), J. Quint (London, United Kingdom)

Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Gayle (London, United Kingdom), E. Axson (London, United Kingdom), C. Bloom (London, United Kingdom), V. Navaratnam (Nottingham, United Kingdom), J. Quint (London, United Kingdom). Changing causes of mortality for people with chronic respiratory diseases. 1934

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The global burden of chronic respiratory diseases
Source: ISSN=ISSN 1810-6838, ISBN=, page=20
Year: 2006

The occupational burden of respiratory diseases
Source: Annual Congress 2009 - Best of ERS
Year: 2009


The development of chronic respiratory failure in patients with different disabling respiratory disorders
Source: Annual Congress 2009 - COPD, chronic respiratory failure and rehabilitation
Year: 2009


The burden of respiratory diseases in a general hospital
Source: Eur Respir J 2001; 18: Suppl. 33, 442s
Year: 2001

Risk factors contributing to mortality in patients with COPD developing acute respiratory failure
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007

Prioritised research agenda for prevention and control of chronic respiratory diseases
Source: Eur Respir J 2010; 36: 995-1001
Year: 2010



Relation between respiratory diseases and the development of cardiovascular events in patients with respiratory viral infection
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020


How resistance is changing the etiology of acute and chronic respiratory infections?
Source: International Congress 2015 – Antibiotic resistance in respiratory infections
Year: 2015



Prevalence and impact of chronic respiratory disease in moderate to severe COVID-19 outcomes
Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19
Year: 2021


The economic burden of respiratory diseases: COPD and asthma
Source: Eur Respir Monogr 2014; 65: 116-124
Year: 2014


The influence of chronic concomitant diseases and age on the risk of death in patients with community-aquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002

The threat in chronic lung diseases: acute exacerbations
Source: Eur Respir Rev, 26 (145) 170075; 10.1183/16000617.0075-2017
Year: 2017



Prevalence of sarcopenia in chronic respiratory hospitalized patients
Source: International Congress 2019 – Oxygen supplementation, noninvasive ventilation and mobility aspects of patients with impaired respiration
Year: 2019


Why do viral respiratory infections cause greater morbidity in children with asthma than in healthy children?
Source: Annual Congress 2012 - Viral respiratory disease in preschool children
Year: 2012


Chronic respiratory care for neuromuscular diseases in adults
Source: Eur Respir J 2010; 35: 1192
Year: 2010


Individual risks of developing chronic bronchitis and respiratory symptoms  in smokers
Source: Virtual Congress 2021 – Health effects of tobacco and medical professionals
Year: 2021


Reducing the risk of COPD exacerbations as results of personalized therapy of co-morbidity with upper respiratory tract diseases
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


Canadian incidence, prevalence and healthcare utilization for respiratory complications of adults with neuromuscular disease
Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis
Year: 2017